Articles from PACS Group, Inc.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that it will restate its previously issued condensed combined/consolidated financial statements as of and for the three months ended on March 31, 2024 included in the Company’s Quarterly Report on Form 10-Q filed with the SEC on May 13, 2024 (as amended on May 21, 2024), and as of and for the three and six months ended on June 30, 2024 included in the Company’s Quarterly Report on Form 10-Q filed with the SEC on August 12, 2024 (collectively, the “Prior Financial Statements,” and each such quarterly period in the six months ended June 30, 2024, the “Impacted Periods”). The Prior Financial Statements and any previously furnished reports or communications of PACS describing the Company’s financial results for the Impacted Periods should no longer be relied upon.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that independent operating subsidiaries of the Company closed on the operations of 11 skilled nursing facilities in Tennessee on December 1, 2024, which collectively comprise 1,310 skilled nursing beds; a 12th facility in Tennessee is expected to close in the first quarter of 2025, subject to the satisfaction of applicable closing conditions. With the expansion into Tennessee, PACS has now acquired a total of 38 facilities since October 31, 2024, adding 4,700 skilled nursing beds to its portfolio.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), today announced that on November 20, 2024 it received a written Filing Delinquency Notification (the “Notification”) from the New York Stock Exchange (“NYSE”) stating that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual, Annual and Quarterly Report Timely Filing Criteria (the “Timely Filing Criteria”), due to the delayed filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2024. The Company was unable to timely file its Form 10-Q due to the ongoing Audit Committee investigation of recent third-party allegations. Pursuant to the Notification, the Company has an initial six month period, from November 19, 2024, to file the Form 10-Q and regain compliance with the Timely Filing Criteria. The Company currently anticipates filing the Form 10-Q and regaining compliance with the Timely Filing Criteria within the initial six month period.

PACS Group, Inc. (NYSE: PACS) (“PACS”) is proud to announce that 36 of its affiliated post-acute communities have been named by U.S. News & World Report to their list of Best Nursing Homes for 2025. Those communities are as follows:

PACS Group, Inc. (NYSE: PACS) (“PACS”) is proud to announce that 17 of its post acute communities have been named by Newsweek Magazine to their Best Nursing Homes for 2025.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), today provided select preliminary key operating metrics for the third quarter and announced the postponement of the release of its third quarter 2024 financial results. PACS expects to release its third quarter 2024 financial results as soon as practicable.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that independently operated subsidiaries of the Company have acquired the operations of 8 skilled nursing facilities in Pennsylvania. The facilities are located in the western Pennsylvania cities of Pittsburgh, Bedford, Bethel Park, Monroeville, and McMurray, and collectively comprise 1,199 skilled nursing beds. Four of the facilities are being leased from an affiliate of CareTrust REIT (NYSE: CTRE), and subsidiaries of the Company acquired the real estate of the remaining four facilities.

PACS Group, Inc. (NYSE: PACS) (“PACS Group” or the “Company”), today announced that it will release its third quarter 2024 financial results after market close on Thursday, November 7, 2024. Management will host a call on Thursday, November 7, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that independent operating subsidiaries of the Company have agreed to acquire the operations of 12 skilled nursing facilities in Tennessee, and collectively comprise 1,310 skilled nursing beds.

PACS Group, Inc. (NYSE: PACS) (“PACS”) has finalized its acquisition of operations of 53 skilled nursing, assisted and independent living facilities from Prestige Care (Prestige), bringing its proven model to new geographical areas.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) today announced the closing of its upsized underwritten public offering of 19,034,482 shares of its common stock, which includes (i) 2,777,778 shares of its common stock sold by the Company and (ii) 16,256,704 shares of common stock sold by certain selling stockholders, which includes the exercise in full by the underwriters of their 30-day option to purchase an additional 2,482,758 shares of common stock from the selling stockholders, at a public offering price of $36.25 per share, for total gross proceeds of approximately $101 million to the Company and approximately $589 million to the selling stockholders, before deducting underwriting discounts and commissions and offering expenses. PACS did not receive any proceeds from any sale of shares by the selling stockholders.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) today announced the pricing of its upsized underwritten public offering of 16,551,724 shares of its common stock, which includes 2,777,778 shares of common stock sold by the Company and 13,773,946 shares of common stock sold by certain selling stockholders, at a public offering price of $36.25 per share, for total gross proceeds of approximately $101 million to the Company and approximately $499 million to the selling stockholders, before deducting underwriting discounts and commissions and offering expenses. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 2,482,758 shares of the Company’s common stock at the public offering price, less underwriting discounts and commissions. PACS will not receive any proceeds from any sale of shares by the selling stockholders. The offering is expected to close on September 9, 2024, subject to customary closing conditions.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) today announced the commencement of an underwritten public offering of 13,888,890 shares of its common stock, including 2,777,778 shares of common stock sold by the Company and 11,111,112 shares of common stock sold by certain selling stockholders. The selling stockholders also expect to grant the underwriters a 30-day option to purchase up to an additional 2,083,332 of shares of common stock. PACS will not receive any proceeds from any sale of shares by the selling stockholders. The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the second quarter of 2024.

PACS Group, Inc. (NYSE: PACS) (“PACS Group” or the “Company”), today announced that it will release its second quarter 2024 financial results after market close on Monday, August 12, 2024. Management will host a call on Monday, August 12, 2024, at 5:00 p.m. Eastern Time to discuss the financial results and related information.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that subsidiaries of the Company have agreed to acquire the operations of 53 skilled nursing and assisted/independent living facilities across 8 western states. The facilities are currently operated by Prestige, a family company whose legacy of caring for seniors dates back to the 1940s.

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”) announced today that Evelyn Dilsaver has been appointed to serve as a member of its Board of Directors. “We’re thrilled to have Evelyn join our board,” said Jason Murray, PACS Chairman and CEO. “She has great experience as an accounting and finance professional, not to mention her work on the boards of several other public companies. She’ll bring added perspective and expertise to the board as we work to guide PACS going forward.”

PACS Group, Inc. (NYSE: PACS) (“PACS” or the “Company”), which together with its subsidiaries is one of the largest post-acute healthcare companies in the United States, announced operating results for the first quarter of 2024, reporting net income of $49.1 million, Adjusted EBITDA of $88.5 million and Adjusted EBITDAR of $152.5 million.

PACS Group, Inc. (NYSE: PACS) (“PACS Group” or the “Company”), today announced that it will release its first quarter 2024 financial results after market close on Monday, May 13, 2024. Management will host a call the following day, Tuesday, May 14, 2024, at 4:00 p.m. Eastern Time to discuss the financial results and related information.

PACS Group, Inc. (“PACS” or the “Company”) today announced the closing of its initial public offering of 21,428,572 shares of its common stock sold by the Company at a public offering price of $21.00 per share, for total gross proceeds of approximately $450 million, before deducting underwriting discounts and commissions and offering expenses. In addition, the underwriters have exercised their 30-day option to purchase an additional 3,214,284 shares of the Company’s common stock at the initial public offering price from the selling stockholders, less underwriting discounts and commissions. PACS did not receive any proceeds from any sale of shares by the selling stockholders. The Company’s common stock is listed on the New York Stock Exchange under the ticker symbol “PACS.”

PACS Group, Inc. (“PACS” or the “Company”) today announced the pricing of its upsized initial public offering of 21,428,572 shares of its common stock being sold by the Company at a public offering price of $21.00 per share, for total gross proceeds of approximately $450 million, before deducting underwriting discounts and commissions and offering expenses. In addition, certain selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 3,214,284 shares of the Company’s common stock at the initial public offering price, less underwriting discounts and commissions. PACS will not receive any proceeds from any sale of shares by the selling stockholders. The shares are expected to begin trading on the New York Stock Exchange on April 11, 2024, under the ticker symbol “PACS.” The offering is expected to close on April 15, 2024, subject to customary closing conditions.

PACS Group, Inc. has named Derick Apt as its new Chief Financial Officer, succeeding Mark Hancock, who held that position since co-founding PACS in 2013. Mr. Hancock will continue to be involved in the company’s executive management in his new role as Executive Vice Chairman. The new roles were both effective January 1, 2024.